Immunoassay Systems

Immunoassay Systems

Global Immunoassay Systems Market to Reach US$29.9 Billion by 2030

The global market for Immunoassay Systems estimated at US$23.2 Billion in the year 2023, is expected to reach US$29.9 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Immunoassay Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$19.4 Billion by the end of the analysis period. Growth in the Immunoassay Analyzers / Instruments segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.3 Billion While China is Forecast to Grow at 6.4% CAGR

The Immunoassay Systems market in the U.S. is estimated at US$6.3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 6.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Immunoassay Systems Market - Key Trends and Drivers Summarized

Immunoassay systems are indispensable tools in clinical diagnostics and biomedical research, employing biochemical tests to measure specific macromolecules or small molecules in complex mixtures. They leverage antibody-based reactions for sensitive and specific detection and quantification of antigens or antibodies in various body fluids, playing a vital role in qualitative and quantitative analysis of biological samples. The market for these systems is poised for continuous growth, driven by technological advancements, the increasing burden of diseases like diabetes and cancer, and the expanding global healthcare infrastructure, especially in managing age-related conditions among the elderly.

Advancements in technology have led to the development of sophisticated immunoassay systems with enhanced sensitivity, faster results, and greater throughput. Technologies such as chemiluminescence immunoassay (CLIA) and enzyme-linked immunosorbent assay (ELISA) are in demand for their improved accuracy and reliability. Moreover, automation and integration with laboratory information systems (LIS) are trends shaping the future of immunoassay systems, reducing human error and enhancing diagnostic workflows. Portable systems for point-of-care testing are also gaining traction, particularly in managing chronic diseases and emergency medicine, where rapid decision-making is crucial.

Additionally, customization, flexibility, and a focus on precision medicine are driving the demand for immunoassay systems tailored to specific laboratory needs. Multiplexed immunoassays, allowing simultaneous measurement of multiple analytes, are gaining popularity for their comprehensive analysis of biological samples. . Immunoassay systems are vital for identifying biomarkers and specific disease states, thus supporting personalized treatment plans. Laboratories are increasingly looking for immunoassay systems that can be customized to their specific needs. Systems that offer flexibility in terms of scalable throughput, open reagent systems, and a broad menu of tests are particularly appealing. Moreover, sustainability and eco-friendliness are becoming key considerations in system design, with manufacturers focusing on reducing energy consumption and waste production, aligning with global sustainability goals.

Select Competitors (Total 29 Featured) -
  • Abbott Laboratories
  • Beckman Coulter Inc.
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A
  • Ortho-Clinical Diagnostics Inc.
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Tosoh Bioscience Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Immunoassay Systems - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Chronic and Infectious Diseases Propels Growth of Immunoassay Systems
Advancements in Immunoassay Technology Spurs Innovation in Diagnostic Capabilities
Growing Adoption in Clinical Diagnostics and Research Expands Addressable Market Opportunity
Enhanced Sensitivity and Specificity Features Strengthens Business Case for Adoption
Increasing Demand for Point-of-Care Testing Generates Opportunities for Immunoassay Systems
Rising Investment in Biotechnology and Pharmaceutical R&D Drives Adoption
Development of Multiplex Immunoassays Propels Innovation in Diagnostics
Expansion of Personalized Medicine and Targeted Therapies Generates Demand
Growing Use of Immunoassays in Drug Development and Clinical Trials Drives Market Adoption
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Immunoassay Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Analyzers / Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Rapid Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Rapid Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Rapid Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Radioimmuno Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Radioimmuno Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Radioimmuno Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Pharmaceutical & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Pharmaceutical & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 41: USA Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 47: USA Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: USA Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: USA 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 50: Canada Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Canada 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 56: Canada Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Canada 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 59: Japan Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Japan 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 65: Japan Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Japan 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 68: China Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: China Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: China 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 74: China Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: China Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: China 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 77: Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Immunoassay Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Europe 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Europe 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 89: France Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: France Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: France 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 95: France Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: France Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: France 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 98: Germany Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Germany 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 104: Germany Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Germany Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Germany 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 107: Italy Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Italy 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 113: Italy Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Italy Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Italy 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 116: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: UK Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: UK 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 122: UK Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: UK Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: UK 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 125: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Spain 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 128: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Spain Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Spain 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 131: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Spain Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Spain 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 134: Russia Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Russia 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 137: Russia Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Russia Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Russia 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 140: Russia Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Russia Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Russia 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of Europe 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Rest of Europe Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Rest of Europe 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Rest of Europe Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Rest of Europe 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Immunoassay Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Asia-Pacific 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Asia-Pacific 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Asia-Pacific 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Asia-Pacific Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Asia-Pacific 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 164: Australia Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Australia 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 167: Australia Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Australia Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Australia 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 170: Australia Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Australia Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Australia 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 173: India Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: India Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: India 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 176: India Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: India Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: India 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 179: India Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: India Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: India 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 182: South Korea Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: South Korea 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 185: South Korea Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: South Korea Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: South Korea 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 188: South Korea Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: South Korea Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: South Korea 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Asia-Pacific Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Asia-Pacific Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 200: Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Immunoassay Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Latin America 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Latin America 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 206: Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Latin America 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 209: Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Latin America Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Latin America 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 212: Argentina Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Argentina 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 215: Argentina Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Argentina Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Argentina 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 218: Argentina Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Argentina Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Argentina 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 221: Brazil Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Brazil 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 224: Brazil Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Brazil Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Brazil 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 227: Brazil Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 228: Brazil Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 229: Brazil 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 230: Mexico Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 232: Mexico 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 233: Mexico Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 234: Mexico Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 235: Mexico 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 236: Mexico Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 237: Mexico Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 238: Mexico 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 241: Rest of Latin America 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 243: Rest of Latin America Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 244: Rest of Latin America 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 246: Rest of Latin America Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 247: Rest of Latin America 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 248: Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Immunoassay Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 250: Middle East 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 253: Middle East 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 254: Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 256: Middle East 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 257: Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 258: Middle East Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 259: Middle East 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 260: Iran Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 262: Iran 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 263: Iran Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 264: Iran Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 265: Iran 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 266: Iran Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 267: Iran Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 268: Iran 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 269: Israel Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 271: Israel 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 272: Israel Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 273: Israel Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 274: Israel 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 275: Israel Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 276: Israel Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 277: Israel 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 280: Saudi Arabia 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 282: Saudi Arabia Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 283: Saudi Arabia 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 285: Saudi Arabia Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 286: Saudi Arabia 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 287: UAE Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 289: UAE 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 290: UAE Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 291: UAE Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 292: UAE 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 293: UAE Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 294: UAE Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 295: UAE 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 298: Rest of Middle East 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 300: Rest of Middle East Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 301: Rest of Middle East 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 303: Rest of Middle East Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 304: Rest of Middle East 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 305: Africa Recent Past, Current & Future Analysis for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Immunoassay Systems by Product - Reagents & Kits, Analyzers / Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 307: Africa 16-Year Perspective for Immunoassay Systems by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Analyzers / Instruments and Software & Services for the Years 2014, 2024 & 2030
TABLE 308: Africa Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 309: Africa Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 310: Africa 16-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassays, Rapid Tests, Radioimmuno Assay and Other Technologies for the Years 2014, 2024 & 2030
TABLE 311: Africa Recent Past, Current & Future Analysis for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 312: Africa Historic Review for Immunoassay Systems by End-Use - Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 313: Africa 16-Year Perspective for Immunoassay Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings